Jasper Therapeutics, Inc.

NasdaqCM:JSPR Stock Report

Market Cap: US$242.9m

Jasper Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:JSPR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Feb 24BuyUS$4,532,500Velan Capital Partners LPCompany350,000US$12.95
08 Feb 24BuyUS$2,460,500Abingworth LLPCompany190,000US$12.95
28 Nov 23BuyUS$6,486Thomas WiggansIndividual1,000US$6.49
21 Nov 23BuyUS$6,383Thomas WiggansIndividual1,000US$6.38
20 Nov 23BuyUS$18,240Thomas WiggansIndividual3,000US$6.31

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of JSPR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders191,5451.21%
Public Companies555,9543.51%
Hedge Funds2,058,19013%
VC/PE Firms3,467,05721.9%
Institutions9,587,24260.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.3%.


Top Shareholders

Top 25 shareholders own 92.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.74%
Velan Capital Partners LP
1,471,904US$23.7m0%28.96%
8.45%
Soleus Capital Management, L.P.
1,276,190US$20.5m7.51%1.73%
7.06%
Abingworth LLP
1,066,189US$17.1m0%5.11%
6.15%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
928,964US$14.9m0%1.55%
5.18%
Avidity Partners Management, L.P.
782,000US$12.6m2.89%0.52%
4.62%
Franklin Resources, Inc.
698,536US$11.2m-3.26%no data
4.59%
BlackRock, Inc.
692,980US$11.1m258%no data
4.57%
The Vanguard Group, Inc.
690,059US$11.1m12.6%no data
3.85%
Polar Capital Holdings Plc
581,538US$9.4m0%0.04%
3.48%
Samsara BioCapital LLC
525,000US$8.4m0%1.72%
3.29%
Kingdon Capital Management, L.L.C.
497,000US$8.0m0%1.21%
3.01%
Roche Holding AG
454,961US$7.3m0%no data
3.01%
Sphera Funds Management Ltd
454,227US$7.3m-10.1%1.18%
2.74%
Woodline Partners LP
413,940US$6.7m9.15%0.07%
2.68%
Rock Springs Capital Management LP
404,335US$6.5m0%0.2%
2.66%
Great Point Partners, LLC
402,015US$6.5m-1.36%1.29%
2.6%
Opaleye Management Inc.
392,000US$6.3m-10%1.1%
2.32%
Tavistock Life Sciences
350,000US$5.6m0%0.29%
2.15%
Bank of America Corporation, Asset Management Arm
325,324US$5.2m1.73%no data
2.04%
Morgan Stanley, Investment Banking and Brokerage Investments
308,499US$5.0m74.9%no data
1.9%
Octagon Capital Advisors LP
287,500US$4.6m-42.6%0.77%
1.72%
Geode Capital Management, LLC
259,754US$4.2m103%no data
1.66%
HBM Partners Ltd.
250,000US$4.0m23.9%0.41%
1.62%
Avego Healthcare Capital, LLC
245,328US$3.9m0%100.0%
1.45%
Ally Bridge Group
218,614US$3.5m-24.6%1.14%